Spruce Biosciences, Inc. Depreciation
Spruce Biosciences, Inc. (SPRB) reported Depreciation of $9.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2022-08-10
- Spruce Biosciences, Inc. depreciation for the quarter ending 2022-06-30 was $9.00K, a 80.00% increase year-over-year.
- Spruce Biosciences, Inc. depreciation for the quarter ending 2022-03-31 was $9.00K, a 125.00% increase year-over-year.
- Spruce Biosciences, Inc. depreciation for the quarter ending 2021-06-30 was $5.00K.
- Spruce Biosciences, Inc. depreciation for the quarter ending 2021-03-31 was $4.00K.
- Spruce Biosciences, Inc. depreciation for fiscal 2021 was $23.00K, a 360.00% increase from fiscal 2020.
- Spruce Biosciences, Inc. depreciation for fiscal 2020 was $5.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 12 month |
|---|---|---|---|
| 2022-06-30 | $9.00K 10-Q · filed 2022-08-10 | $18.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $9.00K 10-Q · filed 2022-05-11 | ||
| 2021-12-31 | $23.00K 10-K · filed 2022-03-14 | ||
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-10 | $9.00K 10-Q · filed 2022-08-10 | |
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-11 | ||
| 2020-12-31 | $5.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |